PRN Benzodiazepine Protocol for Acutely Ill NPO Patients with Alcohol Use History
For an acutely ill, NPO patient with alcohol use history, use midazolam 2.5-5 mg subcutaneously every 2-4 hours PRN, reducing to 0.5-1 mg in elderly or frail patients, with monitoring for respiratory depression and fall risk. 1
Route Selection for NPO Patients
Since the patient cannot take oral medications:
- Subcutaneous midazolam is the preferred route for NPO patients requiring benzodiazepines 1
- Intravenous administration is an alternative if IV access is already established 2
- Avoid intramuscular injection when possible due to local irritation risk 2
Dosing Protocol
Standard Adult Dosing (Age <60-65, No Frailty)
- Initial dose: Midazolam 2.5-5 mg subcutaneously 1
- Frequency: Every 2-4 hours as needed 1
- Maximum assessment interval: Every 1 hour if severely agitated 2
Elderly or Debilitated Patients (Age ≥60-65 or Frail)
- Reduce dose by 50-75%: Midazolam 0.5-1 mg subcutaneously 2
- Use lower end of dosing range initially 3
- Elderly patients have increased risk of excessive sedation with standard doses 3
Renal Impairment Adjustment
- If eGFR <30 mL/min: Reduce continuous infusion dose (if transitioning to infusion, use 5 mg over 24 hours instead of 10 mg) 1
- PRN dosing may require similar reduction in severe renal impairment
Hepatic Impairment
- Use lower doses similar to elderly dosing (0.5-1 mg) 2
- Consider lorazepam as alternative since it has no active metabolites 4
When to Transition to Continuous Infusion
If patient requires midazolam more than twice daily, consider continuous subcutaneous infusion via syringe driver 1:
- Start at 10 mg over 24 hours (standard adult)
- Start at 5 mg over 24 hours if eGFR <30 mL/min 1
Critical Monitoring Parameters
Before Each Dose
- Respiratory rate (hold if <10-12 breaths/minute)
- Oxygen saturation (hold if <90% or significant decline from baseline)
- Level of consciousness (hold if already oversedated)
- Fall risk assessment - benzodiazepines significantly increase fall risk, especially in elderly 2
Ongoing Monitoring
- Vital signs every 2-4 hours minimum when receiving PRN benzodiazepines
- Sedation level using validated scale (e.g., Riker SAS or RASS)
- Paradoxical agitation - benzodiazepines can worsen agitation in some patients 2
- Delirium screening - benzodiazepines themselves can cause or worsen delirium 2
Specific Considerations for Alcohol Withdrawal
If this patient has alcohol withdrawal syndrome (common in hospitalized patients with alcohol use history):
Lorazepam is preferred over midazolam for alcohol withdrawal 4
Thiamine supplementation is mandatory: 100-300 mg/day for 4-12 weeks 4
- Must be given BEFORE any glucose-containing IV fluids 4
Common Pitfalls to Avoid
Do not use benzodiazepines as monotherapy for delirium - they are only indicated for alcohol/benzodiazepine withdrawal delirium or as adjunct when antipsychotics fail 2, 5
Avoid combining benzodiazepines with high-dose olanzapine - fatalities have been reported due to oversedation and respiratory depression 2
Do not use in severe pulmonary insufficiency, severe liver disease, or myasthenia gravis unless patient is imminently dying 2
Watch for respiratory depression when combining with opioids - synergistic effect significantly increases risk 6
Subcutaneous lorazepam may cause local irritation at injection site 2
Alternative Agents if Benzodiazepines Contraindicated
If benzodiazepines cannot be used:
- For anxiety/agitation: Haloperidol 0.5-2 mg IV/SC every 4-6 hours 5, 7
- For alcohol withdrawal specifically: Consider phenobarbital-based protocol under specialist supervision 8
Documentation Requirements
Document with each PRN dose:
- Indication (anxiety, agitation, alcohol withdrawal symptoms)
- Pre-dose vital signs and sedation level
- Dose administered and route
- Post-dose response within 15-30 minutes
- Any adverse effects